Series B · Healthtech

Remedy Robotics raises $62 million Series B led by DCVC

The financing will support clinical trials and regulatory development of its N1 endovascular robot.

Remedy Robotics has raised $62 million in Series B funding. DCVC led the round, joined by UC Investments, Skip Capital, Hostplus, Build Collective, Blackbird, Divergent Capital and KdT Ventures.

The company plans a pivotal trial with the University of California, further regulatory development and prototype deployments with clinical partners. Its N1 system combines robotics, AI and imaging for endovascular procedures. It remains under development and is unavailable for commercial sale.

Use of funds

Pivotal clinical trial

Regulatory development

Prototype deployment with clinical partners

Funding history

Series B · This round$62M

Sources

  1. Remedy Robotics raises $62m Series Bremedyrobotics.com · Nov 9, 2026
  2. Remedy Robotics Series B issuer releaseprnewswire.com · Nov 16, 2026